(file photo)
Speed Post News Network
New Delhi : The Center for Biopharma Analysis (CBA), supported by the National Biopharma Mission (NBM) of Department of Biotechnology (DBT)- Biotechnology Industry Research Assistance Council (BIRAC), at Pune-based technology business incubator, Venture Center, was inaugurated virtually by Secretary, DBT, Dr Renu Swarup.
CBA will provide high-quality analytical services for biopharmaceutical developers and manufacturers. This center is envisioned to become a resource center for structural and functional characterisation of biologicals and biopharmaceuticals that will create long lasting value for bioentrepreneurs and industry.
Inaugurating the facility via video conference, Dr Renu Swarup, Secretary, DBT, said that she expects that the CBA will play a pivotal role in supporting biopharma innovations from academic and government research labs, startups and many Indian companies with not only high-quality analytical characterisation but also advise on studies needed for regulatory approvals, according to a PIB release. This can help speed up the development process.
Also speaking on the occasion, Prof AK Nangia, Director, CSIR-NCL, highlighted how NCL is keen to contribute to the large molecule therapeutics revolution waiting to happen in India as it did for small molecule therapeutics in 1970-80s. Prasanta Biswal, CEO of International Biotech Park Limited, Pune, said that IBPL is happy to have contributed CSR support for the CBA infrastructure development and looks forward to working closely with Venture Center and BIRAC in positioning the Pune Knowledge Cluster for excellence in biopharma and medtech development and manufacturing.
About BIRAC: Biotechnology Industry Research Assistance Council (BIRAC) is a not-for-profit Section 8, Schedule B, Public Sector Enterprise, set up by Department of Biotechnology (DBT), Government of India, as an Interface Agency to strengthen and empower the emerging Biotech enterprise to undertake strategic research and innovation, addressing nationally relevant product development needs.
National Biopharma Mission: The Industry-Academia Collaborative Mission of Department of Biotechnology (DBT), Govt of India, for accelerating discovery research to early development for Biopharmaceuticals approved by the Cabinet for a total cost US$ 250 million and 50% co-funded by the World Bank, is being implemented at Biotechnology Research Assistance Council (BIRAC). This programme is dedicated to deliver affordable products to the nation to improve the health standards of India’s population.
Venture Center: Entrepreneurship Development Center (Venture Center) – a CSIR initiative – is a Section 25 company hosted by the National Chemical Laboratory, Pune. Venture Center strives to nucleate and nurture technology and knowledge-based enterprises by leveraging the scientific and engineering competencies of the institutions in the Pune region in India. The Venture Center is a technology business incubator supported by the Department of Science & Technology’s National Science & Technology Entrepreneurship Development Board (DST-NSTEDB).
About CBA: Center for BioPharma Analysis (CBA) is an initiative of Venture Center supported by the National BioPharma Mission, BIRAC (Government of India). The Venture Center is a technology business incubator hosted by CSIR-National Chemical Laboratory, Pune. It provides open access cutting-edge technologies for Biopharmaceutical Analysis and would emerge as resource center for Characterisation of Biopharmaceuticals.